Hinge Health (NYSE:HNGE) CEO Daniel Antonio Perez Sells 104,544 Shares

Key Points

• CEO Daniel Antonio Perez sold 104,544 Hinge Health shares on May 6 at an average price of $55.09, totaling about $5.76 million. The sale was made under a pre-arranged Rule 10b5-1 trading plan and cut his direct ownership by 74.67%.
• Hinge Health reported stronger-than-expected quarterly results, posting EPS of $0.45 versus the $0.12 consensus estimate on revenue of $182.31 million. Revenue rose 47.2% year over year, though profitability remained deeply negative.
• Analysts remain broadly positive on the stock, with a consensus rating of “Moderate Buy” and an average price target of $67.40. Recent brokerage updates included several reiterated outperform/overweight ratings and higher target prices.

Hinge Health Inc. (NYSE:HNGE - Get Free Report) CEO Daniel Antonio Perez sold 104,544 shares of the firm's stock in a transaction dated Wednesday, May 6th. The stock was sold at an average price of $55.09, for a total transaction of $5,759,328.96. Following the transaction, the chief executive officer directly owned 35,470 shares in the company, valued at approximately $1,954,042.30. This represents a 74.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Daniel Antonio Perez also recently made the following trade(s):

• On Thursday, May 7th, Daniel Antonio Perez sold 45,456 shares of Hinge Health stock. The shares were sold at an average price of $55.05, for a total transaction of $2,502,352.80.
• On Thursday, February 12th, Daniel Antonio Perez sold 166,665 shares of Hinge Health stock. The stock was sold at an average price of $40.26, for a total transaction of $6,709,932.90.

Hinge Health Stock Performance

Shares of HNGE stock traded up $0.89 during trading on Friday, hitting $55.89. The company had a trading volume of 1,861,078 shares, compared to its average volume of 1,251,254. The firm has a market capitalization of $4.40 billion and a P/E ratio of -4.53. Hinge Health Inc. has a one year low of $30.08 and a one year high of $62.18. The stock's 50-day moving average price is $42.81 and its 200 day moving average price is $44.00.

Hinge Health (NYSE:HNGE - Get Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.33. The firm had revenue of $182.31 million during the quarter. Hinge Health had a negative return on equity of 279.39% and a negative net margin of 78.95%.Hinge Health's revenue was up 47.2% on a year-over-year basis. During the same period in the prior year, the firm earned $1.30 earnings per share. On average, research analysts anticipate that Hinge Health Inc. will post 0.78 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently weighed in on HNGE. Weiss Ratings raised shares of Hinge Health from a "sell (e+)" rating to a "sell (d-)" rating in a report on Wednesday. Piper Sandler restated an "overweight" rating and set a $95.00 price objective on shares of Hinge Health in a research report on Wednesday. Raymond James Financial reaffirmed an "outperform" rating and issued a $70.00 target price on shares of Hinge Health in a report on Wednesday. Citigroup reissued an "outperform" rating on shares of Hinge Health in a report on Wednesday. Finally, Royal Bank Of Canada increased their target price on shares of Hinge Health from $55.00 to $65.00 and gave the stock an "outperform" rating in a report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Hinge Health has a consensus rating of "Moderate Buy" and an average price target of $67.40.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Marshall Wace LLP bought a new stake in shares of Hinge Health in the 2nd quarter valued at about $367,000. Sei Investments Co. acquired a new position in shares of Hinge Health in the second quarter worth approximately $869,000. Squarepoint Ops LLC bought a new stake in Hinge Health in the second quarter valued at approximately $19,706,000. Raymond James Financial Inc. acquired a new stake in Hinge Health during the 2nd quarter valued at approximately $3,258,000. Finally, Sandia Investment Management LP bought a new position in Hinge Health during the 2nd quarter worth approximately $657,000.

About Hinge Health

Hinge Health NYSE: HNGE is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company's platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.